1.
Irinotecan in the Treament of Small Cell Lung Cancer (SCLC): A Systematic Review
伊立替康治疗小细胞肺癌的系统评价
2.
Effect of Irinotecan Combined with Radiotherapy in Patients with Advanced Non-small Cell Lung Cancer
伊立替康联合放疗治疗晚期NSCLC的疗效
3.
Clinical comparison between single agent of irinotecan and combination of irinotecan and cispaltin in second-line treatment of small cell lung cancer
伊立替康单药与伊立替康联合顺铂二线治疗小细胞肺癌的临床比较
4.
Preparation of Irinotecan Hydrochloride Liposome and the in Vitro and in Vivo Pharmaceutical Behaviors of Irinotecan Liposome;
伊立替康脂质体的制备及体内外行为研究
5.
Determination of Stabilization of Irinotecan in 0.9% Sodium Chloride Injection by HPLC
伊立替康浓度测定及其输液稳定性考察
6.
Clinical Study of Advanced Ovarial Cancer with Irinotecan and Cisplatin Regimen Combination
伊立替康联合顺铂治疗晚期卵巢癌的疗效观察
7.
The Efficacy Observation of Irinotecan Therapy of Patients with Recurrent Advanced Ovarian Carcinoma
伊立替康治疗复发性晚期卵巢癌的临床观察
8.
CLINICAL OBSERVATION ON THE IRINOTECAN PLUS CISPLATIN FOR ADVANCED ESOPHAGEAL CANCER
伊立替康联合顺铂治疗晚期食管癌疗效观察
9.
Irinotecan combined with capecitabine in line-2 treatment of locally advanced or metastatic gastric cancer
伊立替康联合卡培他滨二线治疗晚期胃癌
10.
Clinical Study of Combination Chemotherapy Based on CPT-11 on Hepatocellular Carcinoma;
伊立替康联合化疗方案治疗原发性肝癌的临床研究
11.
Clinical Study of Weekly Dose of Irinotecan Combined with Low Dose of FP Regiment in the Treatment of Patients with Metastatic Colorectal Cancer;
周剂量伊立替康联合LD-FP持续灌注治疗晚期大肠癌的临床研究
12.
Pharmacokinetic Study of Irinotecan by Co-administered Thalidomide;
合用沙利度胺对盐酸伊立替康药代动力学影响的研究
13.
Observing the Effect of Irinotecan Combined with Capecitabine Regimen on Patients with Metastatic Colon Carcinoma
伊立替康联合卡培他滨治疗转移性结肠癌临床观察
14.
Treatment of extensive-stage small cell lung cancer with irinotecan plus cisplatin
伊立替康联合顺铂治疗广泛期小细胞肺癌的临床观察
15.
Preparation and quality evaluation of irinotecan hydrochloride lyophilized liposomes
盐酸伊立替康脂质体冻干粉针的制备及其质量评价
16.
The combination of capecitabine and irinotecan in treating 38 cases of advanced colorectal cancer as second-line chemtherapy regimen
伊立替康联合卡培他滨二线治疗38例晚期结直肠癌的临床观察
17.
A study on the relationship between the adverse events of irinotecan-based chemotherapy and UGT1A1*28 gene polymorphism
伊立替康化学治疗的不良反应与UGT1A1*28基因多态性的关系
18.
Bacillus licheniformis granules combined with Gentamycin for prevention of irinotecan-induced diarrhea
地衣芽胞杆菌活菌制剂联合庆大霉素预防伊立替康所致腹泻